tiprankstipranks
Advertisement
Advertisement

TSE:TTI Stock Latest News

Thiogenesis Hires Brisco Capital and Moves to Expand Equity Incentive Plan
Company AnnouncementsThiogenesis Hires Brisco Capital and Moves to Expand Equity Incentive Plan
4d ago
Thiogenesis Advances Cystinosis Program With New Study and Phase 3 Plans for TTI-0102
PremiumCompany Announcements
Thiogenesis Advances Cystinosis Program With New Study and Phase 3 Plans for TTI-0102
7M ago
Thiogenesis Posts Positive Phase 2 MELAS Data, Backs Weight-Based Dosing for Lead Mitochondrial Drug
PremiumCompany Announcements
Thiogenesis Posts Positive Phase 2 MELAS Data, Backs Weight-Based Dosing for Lead Mitochondrial Drug
8M ago
Thiogenesis to Present Late-Breaking Phase 2 MELAS Data on TTI-0102 at Mitocon 2026
PremiumCompany Announcements
Thiogenesis to Present Late-Breaking Phase 2 MELAS Data on TTI-0102 at Mitocon 2026
8M ago
Thiogenesis to Showcase Mitochondrial Disease Clinical Progress at UMDF Webinar
PremiumCompany Announcements
Thiogenesis to Showcase Mitochondrial Disease Clinical Progress at UMDF Webinar
8M ago
Thiogenesis Therapeutics Announces Phase 3 Trial for Innovative Cystinosis Treatment
PremiumCompany AnnouncementsThiogenesis Therapeutics Announces Phase 3 Trial for Innovative Cystinosis Treatment
10M ago
Thiogenesis Reports Positive Interim Results and Pipeline Advancements
Premium
Company Announcements
Thiogenesis Reports Positive Interim Results and Pipeline Advancements
10M ago
Thiogenesis Therapeutics Advances in MELAS Treatment with TTI-0102 Study
Premium
Company Announcements
Thiogenesis Therapeutics Advances in MELAS Treatment with TTI-0102 Study
10M ago
TTI
Thiogenesis Therapeutics Advances LSS Treatment with New TTI-0102 Study
PremiumCompany Announcements
Thiogenesis Therapeutics Advances LSS Treatment with New TTI-0102 Study
10M ago
TTI
Thiogenesis Extends Investor Relations Agreement with Capital Analytica
PremiumCompany Announcements
Thiogenesis Extends Investor Relations Agreement with Capital Analytica
11M ago
Thiogenesis Therapeutics Reports AGM Results and Corporate Milestones
PremiumCompany Announcements
Thiogenesis Therapeutics Reports AGM Results and Corporate Milestones
12M ago
Thiogenesis Therapeutics Corp Secures Over C$4.14 Million in Private Placement
PremiumCompany Announcements
Thiogenesis Therapeutics Corp Secures Over C$4.14 Million in Private Placement
1y ago
Thiogenesis Upsizes Private Placement Amid Strong Demand
PremiumCompany AnnouncementsThiogenesis Upsizes Private Placement Amid Strong Demand
1y ago
Thiogenesis Therapeutics Announces $1.5 Million Private Placement to Fund Clinical Trials
Premium
Company Announcements
Thiogenesis Therapeutics Announces $1.5 Million Private Placement to Fund Clinical Trials
1y ago
Thiogenesis Advances Pediatric MASH Trial and Secures EU Patent
Premium
Company Announcements
Thiogenesis Advances Pediatric MASH Trial and Secures EU Patent
1y ago
Thiogenesis to Showcase Promising Mitochondrial Treatments at UMDF Conference
PremiumCompany Announcements
Thiogenesis to Showcase Promising Mitochondrial Treatments at UMDF Conference
1y ago
Thiogenesis Expands Phase 2 MELAS Trial with New French Site
PremiumCompany Announcements
Thiogenesis Expands Phase 2 MELAS Trial with New French Site
1y ago
Thiogenesis Therapeutics Grants Stock Options to Directors
PremiumCompany Announcements
Thiogenesis Therapeutics Grants Stock Options to Directors
1y ago
Thiogenesis Receives FDA Clearance for Phase 2a Trial in Leigh Syndrome
PremiumCompany Announcements
Thiogenesis Receives FDA Clearance for Phase 2a Trial in Leigh Syndrome
1y ago
Thiogenesis Launches Phase 2 Trial for MELAS Treatment
PremiumCompany AnnouncementsThiogenesis Launches Phase 2 Trial for MELAS Treatment
1y ago
Thiogenesis Expands European Reach with New Consultancy Agreement
Premium
Company Announcements
Thiogenesis Expands European Reach with New Consultancy Agreement
2y ago
Thiogenesis Therapeutics Begins OTCQX Trading and Prepares for Phase 2 Trial
Premium
Company Announcements
Thiogenesis Therapeutics Begins OTCQX Trading and Prepares for Phase 2 Trial
2y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >